Increased serum levels of soluble ST2 in birch pollen atopics and individuals working in laboratory animal facilities

Journal of Occupational and Environmental Medicine

Volumn 52, Issue 2, 2010, Pages 214-218

  Sahlander, Karin ^a   Larsson, Kjell ^a   Palmberg, Lena ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CYTOKINE; POLLEN ANTIGEN; SOLUBLE SUPPRESSION OF TUMORIGENICITY 2; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIRCH; BLOOD CELL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL ANIMAL; FEMALE; FLOW CYTOMETRY; HELPER CELL; HUMAN; MALE; POLLEN; PROTEIN EXPRESSION; SKIN TEST;

ANIMALIA;

EID: 77049123016     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/JOM.0b013e3181d09868     Document Type: Article

References (35)

1. Aoyama K, Ueda A, Manda F, Matsushita T, Ueda T, Yamauchi C. Allergy to laboratory animals: an epidemiological study. Br J Ind Med. 1992;49:41-47.
2. Pacheco KA, McCammon C, Thorne PS, et al. Characterization of endotoxin and mouse allergen exposures in mouse facilities and research laboratories. Ann Occup Hyg. 2006;50:563-572.
3. Hollander A, Gordon S, Renstrom A, et al. Comparison of methods to assess airborne rat and mouse allergen levels. I. Analysis of air samples. Allergy. 1999;54:142-149. (Pubitemid 29152063)
4. Renstrom A, Gordon S, Hollander A, et al. Comparison of methods to assess airborne rat and mouse allergen levels. II. Factors influencing antigen detection. Allergy. 1999;54:150-157. (Pubitemid 29152064)
5. Lieutier-Colas F, Meyer P, Pons F, et al. Prevalence of symptoms, sensitization to rats, and airborne exposure to major rat allergen (Rat n 1) and to endotoxin in rat-exposed workers: a cross-sectional study. Clin Exp Allergy. 2002;32:1424-1429.
6. Braun-Fahrlander C, Lauener R. Farming and protective agents against allergy and asthma. Clin Exp Allergy. 2003;33:409-411.
7. Lauener RP, Birchler T, Adamski J, et al. Expression of CD14 and toll-like receptor 2 in farmers' and non-farmers' children. Lancet. 2002; 360:465-466.
8. Tse K, Horner AA. Allergen tolerance versus the allergic march: the hygiene hypothesis revisited. Curr Allergy Asthma Rep. 2008;8:475-483.
9. von Mutius E. Allergies, infections and the hygiene hypothesis-the epidemiological evidence. Immunobiology. 2007;212:433-439.
10. Schroder NW. The role of innate immunity in the pathogenesis of asthma. Curr Opin Allergy Clin Immunol. 2009;9:38-43.
11. Alexis N, Eldridge M, Reed W, Bromberg P, Peden DB. CD14-dependent airway neutrophil response to inhaled LPS: role of atopy. J Allergy Clin Immunol. 2001;107:31-35.
12. Michel O, Ginanni R, Duchateau J, Vertongen F, Le Bon B, Sergysels R. Domestic endotoxin exposure and clinical severity of asthma. Clin Exp Allergy. 1991;21:441-448.
13. Takeda K, Akira S. Toll-like receptors. Curr Protoc Immunol. 2007; Chapter 14: Unit 14.12.
14. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol. 2003;21:335-376.
15. Kawai T, Akira S. Signaling to NF-kappaB by Toll-like receptors. Trends Mol Med. 2007;13:460-469.
16. Uematsu S, Akira S. Toll-like receptors and innate immunity. J Mol Med. 2006;84:712-725.
17. Uematsu S, Akira S. Toll-like receptors and type I interferons. J Biol Chem. 2007;282:15319-15323.
18. Alexis NE, Lay JC, Almond M, Peden DB. Inhalation of low-dose endotoxin favors local T(H)2 response and primes airway phagocytes in vivo. J Allergy Clin Immunol. 2004;114:1325-1331.
19. Li H, Tago K, Io K, et al. The cloning and nucleotide sequence of human ST2L cDNA. Genomics. 2000;67:284-290.
20. Tominaga S, Yokota T, Yanagisawa K, Tsukamoto T, Takagi T, Tetsuka T. Nucleotide sequence of a complementary DNA for human ST2. Biochim Biophys Acta. 1992;1171:215-218.
21. Schmitz J, Owyang A, Oldham E, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity. 2005;23:479-490.
22. Brint EK, Xu D, Liu H, et al. ST2 is an inhibitor of interleukin 1 receptor and toll-like receptor 4 signaling and maintains endotoxin tolerance. Nat Immunol. 2004;5:373-379.
23. Liew FY, Liu H, Xu D. A novel negative regulator for IL-1 receptor and toll-like receptor 4. Immunol Lett. 2005;96:27-31.
24. Sweet MJ, Leung BP, Kang D, et al. A novel pathway regulating lipopolysaccharide- induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression. J Immunol. 2001;166:6633-6639.
25. Hayakawa H, Hayakawa M, Kume A, Tominaga S. Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. J Biol Chem. 2007;282:26369-26380.
26. Ulevitch RJ. Recognition of bacterial endotoxins by receptor-dependent mechanisms. Adv Immunol. 1993;53:267-289.
27. Ulevitch RJ, Tobias PS. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol. 1995;13:437-457.
28. LeVan TD, Guerra S, Klimecki W, et al. The impact of CD14 polymorphisms on the development of soluble CD14 levels during infancy. Genes Immun. 2006;7:77-80.
29. Baldini M, Lohman IC, Halonen M, Erickson RP, Holt PG, Martinez FD. A Polymorphism* in the 5- flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol. 1999;20:976-983.
30. Xu D, Chan WL, Leung BP, et al. Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J Exp Med. 1998;187:787-794. (Pubitemid 28115194)
31. Moritz DR, Rodewald HR, Gheyselinck J, Klemenz R. The IL-1 receptorrelated T1 antigen is expressed on immature and mature mast cells and on fetal blood mast cell progenitors. J Immunol. 1998;161:4866-4874.
32. Ali M, Zhang G, Thomas WR, et al. Investigations into the role of ST2 in acute asthma in children. Tissue Antigens. 2009;73:206-212.
33. Kearley J, Buckland KF, Mathie SA, Lloyd CM. Resolution of allergic inflammation and airway hyperreactivity is dependent upon disruption of the T1/ST2-IL-33 pathway. Am J Respir Crit Care Med. 2009;179:772-781.
34. Oshikawa K, Kuroiwa K, Tago K, et al. Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation. Am J Respir Crit Care Med. 2001;164:277-281.
35. Tajima S, Bando M, Ohno S, et al. ST2 gene induced by type 2 helper T cell (Th2) and proinflammatory cytokine stimuli may modulate lung injury and fibrosis. Exp Lung Res. 2007;33:81-97.